News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
838,405 Results
Type
Article (86358)
Company Profile (648)
Press Release (751388)
Multimedia
Podcasts (151)
Webinars (23)
Section
Business (232037)
Career Advice (4125)
Deals (39693)
Drug Delivery (128)
Drug Development (90692)
Employer Resources (201)
FDA (18077)
Job Trends (17350)
News (395385)
Policy (39827)
Tag
Academia (2985)
Academic (1)
Accelerated approval (13)
Adcomms (26)
Allergies (90)
Alliances (56634)
ALS (70)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (119)
Approvals (18042)
Artificial intelligence (258)
Autoimmune disease (18)
Automation (15)
Bankruptcy (403)
Best Places to Work (12388)
BIOSECURE Act (18)
Biosimilars (114)
Biotechnology (436)
Bladder cancer (64)
Brain cancer (26)
Breast cancer (224)
Cancer (1771)
Cardiovascular disease (171)
Career advice (3542)
Career pathing (33)
CAR-T (116)
CDC (40)
Cell therapy (349)
Cervical cancer (18)
Clinical research (71850)
Collaboration (685)
Company closure (2)
Compensation (508)
Complete response letters (43)
COVID-19 (2826)
CRISPR (47)
C-suite (215)
Cystic fibrosis (92)
Data (1727)
Decentralized trials (2)
Denatured (58)
Depression (61)
Diabetes (216)
Diagnostics (6786)
Digital health (21)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (110)
Drug pricing (145)
Drug shortages (27)
Duchenne muscular dystrophy (116)
Earnings (96377)
Editorial (47)
Employer branding (25)
Employer resources (167)
Events (126647)
Executive appointments (439)
FDA (19351)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (572)
Gene editing (81)
Generative AI (23)
Gene therapy (298)
GLP-1 (770)
Government (5277)
Grass and pollen (6)
Guidances (279)
Healthcare (20695)
HIV (25)
Huntington's disease (22)
IgA nephropathy (21)
Immunology and inflammation (107)
Immuno-oncology (9)
Indications (23)
Infectious disease (2954)
Inflammatory bowel disease (138)
Inflation Reduction Act (13)
Influenza (48)
Intellectual property (112)
Interviews (814)
IPO (17759)
IRA (51)
Job creations (5188)
Job search strategy (2862)
Kidney cancer (3)
Labor market (67)
Layoffs (563)
Leadership (25)
Legal (10095)
Liver cancer (73)
Longevity (7)
Lung cancer (260)
Lymphoma (141)
Machine learning (8)
Management (63)
Manufacturing (402)
MASH (73)
Medical device (14503)
Medtech (14516)
Mergers & acquisitions (22426)
Metabolic disorders (631)
Multiple sclerosis (66)
NASH (22)
Neurodegenerative disease (79)
Neuropsychiatric disorders (25)
Neuroscience (1841)
NextGen: Class of 2025 (7649)
Non-profit (5064)
Now hiring (52)
Obesity (332)
Opinion (280)
Ovarian cancer (44)
Pain (71)
Pancreatic cancer (61)
Parkinson's disease (113)
Partnered (24)
Patents (295)
Patient recruitment (96)
Peanut (52)
People (64587)
Pharmaceutical (131)
Pharmacy benefit managers (18)
Phase I (21972)
Phase II (31160)
Phase III (23650)
Pipeline (1627)
Policy (235)
Postmarket research (3538)
Preclinical (9962)
Press Release (72)
Prostate cancer (93)
Psychedelics (38)
Radiopharmaceuticals (249)
Rare diseases (330)
Real estate (7397)
Recruiting (76)
Regulatory (26720)
Reports (59)
Research institute (2652)
Resumes & cover letters (649)
Rett syndrome (2)
RNA editing (7)
RSV (34)
Schizophrenia (67)
Series A (80)
Series B (61)
Service/supplier (26)
Sickle cell disease (40)
Special edition (24)
Spinal muscular atrophy (159)
Sponsored (38)
Startups (4286)
State (2)
Stomach cancer (10)
Supply chain (69)
Tariffs (42)
The Weekly (91)
Vaccines (761)
Venture capital (48)
Weight loss (261)
Women's health (43)
Worklife (20)
Date
Today (18)
Last 7 days (236)
Last 30 days (1048)
Last 365 days (17061)
2025 (11813)
2024 (30270)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1268)
Alabama (54)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (49734)
Australia (8717)
California (4183)
Canada (2007)
China (371)
Colorado (242)
Connecticut (202)
Delaware (126)
Europe (114334)
Florida (699)
Georgia (170)
Hawaii (2)
Idaho (65)
Illinois (546)
India (33)
Indiana (291)
Iowa (9)
Japan (177)
Kansas (111)
Kentucky (24)
Louisiana (13)
Maine (65)
Maryland (754)
Massachusetts (3295)
Michigan (224)
Minnesota (379)
Mississippi (4)
Missouri (64)
Montana (27)
Nebraska (26)
Nevada (66)
New Hampshire (61)
New Jersey (1534)
New Mexico (24)
New York (1409)
North Carolina (1034)
North Dakota (9)
Northern California (1743)
Ohio (200)
Oklahoma (13)
Oregon (43)
Pennsylvania (1230)
Puerto Rico (10)
Rhode Island (33)
South America (1650)
South Carolina (19)
Southern California (1694)
Tennessee (81)
Texas (765)
United States (18556)
Utah (124)
Virginia (108)
Washington D.C. (55)
Washington State (500)
West Virginia (4)
Wisconsin (52)
838,405 Results for "biospace is a dhi service".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Greener Pastures? 81% of Employed Biopharma Professionals Want New Jobs,
BioSpace
Finds
Employed biopharma professionals are highly likely to look for new jobs in the next 12 months, although not quite as likely as their unemployed counterparts, according to a
BioSpace
LinkedIn poll. Three recruitment experts discuss the findings and what’s driving job searches.
July 31, 2025
·
4 min read
·
Angela Gabriel
Layoff Tracker
Merck To Cut 125 Employees as It Ends UK R&D Work
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
September 12, 2025
·
198 min read
·
BioSpace Editorial Staff
GLP-1
BioSpace
Presents the World Atlas of GLP-1s
Eli Lilly and Novo Nordisk are in a global battle for dominance in the weight loss space.
BioSpace
takes a look at the territory covered and what’s to come.
March 26, 2025
·
2 min read
·
Annalee Armstrong
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
PODCAST
The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know
In this episode of Denatured, BioSpace’s head of insights Lori Ellis discusses the ‘enormous implications’ of patent policy changes with Aaron Cummings and Anne Li of Brownstein Hyatt Farber Schreck.
August 14, 2025
·
1 min read
·
Lori Ellis
Job Trends
BioSpace
Showcases Life Sciences Hubs in 2025 Hotbed Maps
BioSpace
has revealed its 2025 Hotbed Maps, showcasing nine regional hot spots for life sciences activity.
January 21, 2025
·
1 min read
·
Chantal Dresner
IN PARTNERSHIP WITH TACONIC BIOSCIENCES
The ‘Research Safety Net’ Saving Scientists from Funding Crisis
In this episode presented by Taconic Biosciences, BioSpace’s head of insights Lori Ellis discusses how preclinical research companies are helping drug developers navigate the current challenging funding environment with Mike Garrett, CEO.
September 4, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark Mackey, CSO of Cresset.
August 21, 2025
·
1 min read
·
Lori Ellis
Job Trends
Over Half of Biopharma Professionals Work More Hours Than Average US Workers,
BioSpace
Finds
Although U.S. full-time employees worked an average of 42.9 hours weekly last year, according to Gallup, that wasn’t true for most
BioSpace
LinkedIn poll respondents. A Karius HR executive discusses a few potential reasons for the longer workweeks.
April 3, 2025
·
3 min read
·
Angela Gabriel
Job Trends
Report: U.S. Life Sciences Job Market Report Q2 2025
The life sciences job market continues to shift.
BioSpace
’s Q2 2025 U.S. Life Sciences Job Market Report is now available, offering exclusive insights into the latest hiring trends, layoffs, and workforce dynamics across the life sciences industry.
July 17, 2025
·
1 min read
·
BioSpace Insights
1 of 83,841
Next
